What to expect when you take Terazosin hydrochloride and have Diabetes - type 2?

Do you take Terazosin hydrochloride and have Diabetes - type 2? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here



On Jun, 25, 2018

1,683 reports have been studied.


Females aged 50 to 59 :

289 related reports were analyzed:

Most common symptoms:

Abdominal pain upper
  • 9.0% for females aged 50 (±5) who take Terazosin hydrochloride
Abscess (pus)
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Acute kidney failure
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  • 9.69% for females aged 50 (±5) who take Terazosin hydrochloride
Arrhythmias (irregular heartbeat)
  • 5.88% for females aged 50 (±5) who take Terazosin hydrochloride
Back pain
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Bone disorder
  • 6.57% for females aged 50 (±5) who take Terazosin hydrochloride
Bronchopleural fistula
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Cerebrovascular disorder (disease of brain)
  • 6.23% for females aged 50 (±5) who take Terazosin hydrochloride
Cervical spinal stenosis (narrowing of the spinal canal in the neck)
  • 5.88% for females aged 50 (±5) who take Terazosin hydrochloride
Chest pain
  • 13.84% for females aged 50 (±5) who take Terazosin hydrochloride
Chronic fatigue syndrome (disorder that causes extreme fatigue)
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Constipation
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Cough
  • 10.03% for females aged 50 (±5) who take Terazosin hydrochloride
Cyst (a closed sac)
  • 5.88% for females aged 50 (±5) who take Terazosin hydrochloride
Depression
  • 12.11% for females aged 50 (±5) who take Terazosin hydrochloride
Diarrhea
  • 11.07% for females aged 50 (±5) who take Terazosin hydrochloride
Dizziness
  • 6.23% for females aged 50 (±5) who take Terazosin hydrochloride
Drowsiness
  • 7.27% for females aged 50 (±5) who take Terazosin hydrochloride
Dyspnea (difficult or laboured breathing)
  • 7.96% for females aged 50 (±5) who take Terazosin hydrochloride
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Empyema (collection of pus in a cavity in the body)
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Endocarditis (inflammation in heart muscle)
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Enlarged heart
  • 7.96% for females aged 50 (±5) who take Terazosin hydrochloride
Eye discharge
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Faecal incontinence (a lack of control over passing stool)
  • 5.88% for females aged 50 (±5) who take Terazosin hydrochloride
Fall
  • 12.11% for females aged 50 (±5) who take Terazosin hydrochloride
Fatigue (feeling of tiredness)
  • 9.34% for females aged 50 (±5) who take Terazosin hydrochloride
Fever
  • 9.34% for females aged 50 (±5) who take Terazosin hydrochloride
Fibula fracture
  • 5.88% for females aged 50 (±5) who take Terazosin hydrochloride
Foot deformity (functional disability of foot)
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Foot fracture
  • 5.88% for females aged 50 (±5) who take Terazosin hydrochloride
Gait disturbance
  • 5.88% for females aged 50 (±5) who take Terazosin hydrochloride
Gastritis (inflammation of stomach)
  • 10.03% for females aged 50 (±5) who take Terazosin hydrochloride
Gastroesophageal reflux disease (a condition in which stomach contents leak backward from the stomach into the oesophagus)
  • 10.03% for females aged 50 (±5) who take Terazosin hydrochloride
Generalized anxiety disorder (excessive, uncontrollable, unexplained and often irrational worry)
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Headache (pain in head)
  • 6.57% for females aged 50 (±5) who take Terazosin hydrochloride
High blood pressure
  • 11.42% for females aged 50 (±5) who take Terazosin hydrochloride
Hydropneumothorax (presence of both air and fluid in the pleural space (lungs))
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Hypoacusis (loss of hearing)
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Injury
  • 7.96% for females aged 50 (±5) who take Terazosin hydrochloride
Injury corneal
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Insomnia (sleeplessness)
  • 6.23% for females aged 50 (±5) who take Terazosin hydrochloride
Irritable bowel syndrome
  • 6.57% for females aged 50 (±5) who take Terazosin hydrochloride
Itching
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Joint pain
  • 5.88% for females aged 50 (±5) who take Terazosin hydrochloride
Lip and/or oral cavity cancer (cancer of lip or mouth)
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Lip discoloration
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Lung infection
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Mastication disorder (disease of chewing food)
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Menopause (end of monthly cycles in women)
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Migraine with aura (headache with vision weakness)
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Nausea (feeling of having an urge to vomit)
  • 13.15% for females aged 50 (±5) who take Terazosin hydrochloride
Neuropathy peripheral (surface nerve damage)
  • 6.57% for females aged 50 (±5) who take Terazosin hydrochloride
Oedema peripheral (superficial swelling)
  • 18.34% for females aged 50 (±5) who take Terazosin hydrochloride
Oropharyngeal pain
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  • 6.57% for females aged 50 (±5) who take Terazosin hydrochloride
Osteonecrosis of jaw (death of bone of jaw)
  • 7.27% for females aged 50 (±5) who take Terazosin hydrochloride
Osteopenia (a condition where bone mineral density is lower than normal)
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Osteoporosis (bones weak and more likely to break)
  • 5.88% for females aged 50 (±5) who take Terazosin hydrochloride
Osteoradionecrosis (irradiation of bones causes damage to osteocytes and impairs the blood supply)
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Pain
  • 13.84% for females aged 50 (±5) who take Terazosin hydrochloride
Pain in extremity
  • 8.65% for females aged 50 (±5) who take Terazosin hydrochloride
Pain in jaw
  • 6.92% for females aged 50 (±5) who take Terazosin hydrochloride
Panic disorder
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Rashes (redness)
  • 11.42% for females aged 50 (±5) who take Terazosin hydrochloride
Renal failure acute (rapid kidney dysfunction)
  • 6.57% for females aged 50 (±5) who take Terazosin hydrochloride
Retching (strong involuntary effort to vomit)
  • 9.69% for females aged 50 (±5) who take Terazosin hydrochloride
Rib fracture
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Rotator cuff syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder)
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Sinusitis (inflammation of sinus)
  • 7.96% for females aged 50 (±5) who take Terazosin hydrochloride
Sleep apnea syndrome
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Spinal osteoarthritis (joint cartilage loss in spine)
  • 7.61% for females aged 50 (±5) who take Terazosin hydrochloride
Stress and anxiety
  • 13.49% for females aged 50 (±5) who take Terazosin hydrochloride
Tibia fracture (fracture of lower leg bone)
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Tooth disorder (tooth disease)
  • 9.69% for females aged 50 (±5) who take Terazosin hydrochloride
Tooth fracture
  • 9.34% for females aged 50 (±5) who take Terazosin hydrochloride
Toothaches (tooth pain)
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  • 8.3% for females aged 50 (±5) who take Terazosin hydrochloride
Urinary incontinence (inability to control the flow of urine and involuntary urination)
  • 6.23% for females aged 50 (±5) who take Terazosin hydrochloride
Vision blurred
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Weakness
  • 10.73% for females aged 50 (±5) who take Terazosin hydrochloride
Wound infection staphylococcal
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride

Most common co-existing conditions:

Arthritis (form of joint disorder that involves inflammation of one or more joints)
  • 6.92% for females aged 50 (±5) who take Terazosin hydrochloride
Bone density abnormal
  • 5.19% for females aged 50 (±5) who take Terazosin hydrochloride
Diabetes
  • 5.88% for females aged 50 (±5) who take Terazosin hydrochloride
Gastroesophageal reflux disease (a condition in which stomach contents leak backward from the stomach into the oesophagus)
  • 6.23% for females aged 50 (±5) who take Terazosin hydrochloride
Hormone replacement therapy
  • 5.54% for females aged 50 (±5) who take Terazosin hydrochloride
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  • 8.3% for females aged 50 (±5) who take Terazosin hydrochloride
back to top

Males aged 50 to 59 :

1,394 related reports were analyzed:

Most common symptoms:

Chest pain
  • 5.16% for males aged 50 (±5) who take Terazosin hydrochloride
Dizziness
  • 5.09% for males aged 50 (±5) who take Terazosin hydrochloride
Fatigue (feeling of tiredness)
  • 6.31% for males aged 50 (±5) who take Terazosin hydrochloride
Hypotension (abnormally low blood pressure)
  • 5.88% for males aged 50 (±5) who take Terazosin hydrochloride
Nausea (feeling of having an urge to vomit)
  • 6.38% for males aged 50 (±5) who take Terazosin hydrochloride
Pain
  • 5.16% for males aged 50 (±5) who take Terazosin hydrochloride
Weakness
  • 8.25% for males aged 50 (±5) who take Terazosin hydrochloride

Most common co-existing conditions:

High blood cholesterol
  • 5.38% for males aged 50 (±5) who take Terazosin hydrochloride
Related Tests
back to top

Related studies

terazosin hydrochloride

Terazosin hydrochloride has active ingredients of terazosin hydrochloride. It is often used in prostate examination abnormal. (latest outcomes from Terazosin hydrochloride 1,557 users)

diabetes - type 2

Diabetes - type 2 has been reported by people with high blood cholesterol, low density lipoprotein increased, depression, bipolar disorder (latest reports from 199,001 Diabetes - type 2 patients).

Terazosin hydrochloride and Diabetes - type 2

Analysis tools (to study 526 million drug outcomes from FDA)

  • Check symptoms - identify the cause of a symptom: from a drug or from a condition?
  • Check drugs - find out common side effects or drug interactions of my drugs.
  • Compare drugs - compare the side effects and efficacy of multiple drugs side by side.

You are not alone. Join our personalized support groups:

You may be interested in these posts

More posts for: Terazosin hydrochloride, Diabetes - type 2

Recent updates

General studies
Active Support Groups
Recent Predictions

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.